Kirax   Report issue

For profit Phase 2
Founded: Bonita Springs FL United States (2005)
Status: Defunct (2016)

Organization Overview

First Clinical Trial
2006
NCT00285207
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (4)

afp464 (1 trial)

aminoflavone prodrug (1 trial)

fulvestrant (faslodex) (1 trial)

sivifene (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 2)

Cervical Intraepithelial Neoplasia (Phase 2)

Neoplasms (Phase 2)

Squamous Intraepithelial Lesions of the Cervix (Phase 2)

Uterine Cervical Dysplasia (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 4